Valiant Organics Limited (BOM:540145)
India · Delayed Price · Currency is INR 275.20
-0.55 (-0.20%)
At close: Feb 12, 2026
Valiant Organics Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Operating Revenue | 7,524 | 7,188 | 7,231 | 10,518 | 11,533 | 7,548 |
| 7,524 | 7,188 | 7,231 | 10,518 | 11,533 | 7,548 | |
Revenue Growth (YoY) | 16.43% | -0.59% | -31.25% | -8.80% | 52.79% | 11.83% |
Cost of Revenue | 4,809 | 4,746 | 5,079 | 7,098 | 7,944 | 4,274 |
Gross Profit | 2,715 | 2,442 | 2,152 | 3,420 | 3,588 | 3,274 |
Selling, General & Admin | 467.04 | 449.89 | 503.22 | 473 | 376.4 | 297.47 |
Other Operating Expenses | 1,434 | 1,456 | 1,270 | 1,299 | 1,154 | 920.17 |
Operating Expenses | 2,275 | 2,264 | 2,123 | 2,064 | 1,827 | 1,402 |
Operating Income | 440.58 | 177.76 | 29.09 | 1,356 | 1,762 | 1,872 |
Interest Expense | -207 | -236.39 | -163.43 | -107.93 | -64.79 | -49.98 |
Interest & Investment Income | 21.74 | 21.74 | 3.14 | 4.03 | 8.63 | 5.17 |
Earnings From Equity Investments | 17.29 | -7.62 | -15.65 | - | - | - |
Currency Exchange Gain (Loss) | 1.41 | 1.41 | 4.16 | -5.36 | -9.23 | -4.7 |
Other Non Operating Income (Expenses) | 33.05 | 49.44 | 56.34 | 51.52 | 65.2 | 54.16 |
EBT Excluding Unusual Items | 307.06 | 6.34 | -86.35 | 1,298 | 1,761 | 1,877 |
Impairment of Goodwill | - | - | - | - | - | -28.16 |
Gain (Loss) on Sale of Investments | 13.57 | 13.57 | 30.09 | 24.13 | - | - |
Gain (Loss) on Sale of Assets | 1.61 | 1.61 | 3.44 | 0.64 | 0.35 | 0.06 |
Other Unusual Items | - | - | -34.11 | 48.98 | - | - |
Pretax Income | 322.24 | 21.52 | -86.93 | 1,372 | 1,762 | 1,849 |
Income Tax Expense | 86.98 | 55.79 | -2.97 | 346.16 | 482.57 | 539.9 |
Earnings From Continuing Operations | 235.26 | -34.28 | -83.97 | 1,026 | 1,279 | 1,309 |
Minority Interest in Earnings | 0.07 | -3.09 | 0.05 | -144.43 | -146.29 | -163.06 |
Net Income | 235.33 | -37.36 | -83.91 | 881.21 | 1,133 | 1,146 |
Net Income to Common | 235.33 | -37.36 | -83.91 | 881.21 | 1,133 | 1,146 |
Net Income Growth | - | - | - | -22.21% | -1.12% | -7.56% |
Shares Outstanding (Basic) | 27 | 28 | 27 | 27 | 27 | 26 |
Shares Outstanding (Diluted) | 27 | 28 | 27 | 28 | 28 | 28 |
Shares Change (YoY) | -1.35% | 1.13% | -2.43% | 0.03% | - | - |
EPS (Basic) | 8.57 | -1.35 | -3.07 | 32.45 | 41.72 | 44.68 |
EPS (Diluted) | 8.56 | -1.35 | -3.07 | 31.50 | 40.51 | 40.97 |
EPS Growth | - | - | - | -22.24% | -1.12% | -7.56% |
Free Cash Flow | 401.4 | 256.03 | 90.67 | 862.19 | -1,534 | -562.54 |
Free Cash Flow Per Share | 14.61 | 9.28 | 3.32 | 30.82 | -54.86 | -20.12 |
Dividend Per Share | - | - | - | 1.000 | 3.500 | 5.000 |
Dividend Growth | - | - | - | -71.43% | -30.00% | -9.09% |
Gross Margin | 36.09% | 33.97% | 29.76% | 32.51% | 31.12% | 43.37% |
Operating Margin | 5.86% | 2.47% | 0.40% | 12.89% | 15.27% | 24.80% |
Profit Margin | 3.13% | -0.52% | -1.16% | 8.38% | 9.82% | 15.18% |
Free Cash Flow Margin | 5.33% | 3.56% | 1.25% | 8.20% | -13.30% | -7.45% |
EBITDA | 812.54 | 533.46 | 375.28 | 1,643 | 2,037 | 2,052 |
EBITDA Margin | 10.80% | 7.42% | 5.19% | 15.62% | 17.67% | 27.18% |
D&A For EBITDA | 371.96 | 355.7 | 346.19 | 287.34 | 275.92 | 179.88 |
EBIT | 440.58 | 177.76 | 29.09 | 1,356 | 1,762 | 1,872 |
EBIT Margin | 5.86% | 2.47% | 0.40% | 12.89% | 15.27% | 24.80% |
Effective Tax Rate | 26.99% | 259.30% | - | 25.23% | 27.39% | 29.21% |
Revenue as Reported | 7,594 | 7,274 | 7,324 | 10,598 | 11,607 | 7,607 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.